Evidence mapPaperPMID 41405754Full record

SynthesisJournal of thrombosis and thrombolysis2026

Artificial intelligence in computational modeling of thrombosis: Bridging mechanistic insights and clinical translation.

Mohamad Al Bannoud, Tiago Dias Martins, Silmara Aparecida de Lima Montalvão, Joyce Maria Annichino-Bizzacchi, Rubens Maciel Filho, Maria Regina Wolf Maciel

Abstract readSystematic ReviewReview
PubMed Publisher
In one paragraph

Synthesis in Journal of thrombosis and thrombolysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohamad Al BannoudSchool of Chemical Engineering, Laboratory of Optimization, Design, and Advanced Control, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil. mohamad.bannoud@unifesp.br.ORCID http://orcid.org/0000-0003-2491-7297
Tiago Dias MartinsDepartamento de Engenharia Química, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Diadema, São Paulo, Brazil.
Silmara Aparecida de Lima MontalvãoHematology and Hemotherapy Center, University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, São Paulo, Brazil.
Joyce Maria Annichino-BizzacchiHematology and Hemotherapy Center, University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, São Paulo, Brazil.
Rubens Maciel FilhoSchool of Chemical Engineering, Laboratory of Optimization, Design, and Advanced Control, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.
Maria Regina Wolf MacielSchool of Chemical Engineering, Laboratory of Optimization, Design, and Advanced Control, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 164134/2022-0Fundação de Amparo à Pesquisa do Estado de São Paulo 08/57860-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/14172-6
6 · The paper itself

Abstract

Thrombosis presents significant healthcare challenges due to its complex nature. Recent advancements in data-driven mathematical and computational models of blood clot formation offer promising insights. The integration of machine learning (ML) and computational methods in thrombosis research is still in its early stages, but it could leverage the strengths of both approaches. This systematic review followed the PRISMA methodology to assess studies that (i) utilized computational models, (ii) modeled blood clot formation or thrombin generation through the coagulation cascade, and (iii) incorporated ML algorithms. We identified 11 eligible studies that focused on platelet signaling, outcome prediction, thrombin threshold prediction, shear rate prediction, and multiscale modeling. Artificial neural networks and support vector machines were the most commonly used ML models. The hybrid approach combining ML and computational models is still nascent but shows significant promise for advancing thrombosis research. These models offer valuable insights for improving thrombosis diagnosis, prognosis, and treatment, particularly in the context of personalized medicine for hemostatic disorders. The integration of ML with computational models holds great potential for improving thrombosis management, but further research is needed. Future work should focus on enhancing the physiological realism of these models, incorporating patient-specific data, and addressing challenges related to data standardization and clinical implementation. The field is in its early stages but shows promising growth potential and is well positioned to advance precision medicine approaches in thrombosis and hemostatic disorders.

Indexed as

Artificial IntelligenceComputer SimulationThrombosisBlood CoagulationHumansMachine LearningPredictive Learning ModelsSoft ComputingTranslational Research, BiomedicalCoagulation cascadeComputational modelingMachine learningPersonalized medicineThrombosis

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.